The American Cancer Society Cancer Action Network Welcomes HHS Focus on Streamlining and Strengthening Clinical Research
WASHINGTON, D.C. – Yesterday, the U.S.
National Press Releases
ACS CAN Applauds CMS Proposed Rule for Prior Authorization for Drugs and Outlines Further Improvements to Benefit Cancer Patients and Survivors
WASHINGTON, D.C. – Today, the American Cancer Society Cancer Action Network (ACS CAN) submitted comments in a letter to the Department of Health and Hu
House Committee Considers FY27 Appropriations Bill with Boost to Cancer Research and Prevention Funding
Today, the House Committee on Appropriations considered and approved its draft FY27 appropriations bill and accompanying House Report that includes increases for the National Institutes of Health (NIH), the National Cancer Institute (NCI), and the Center for Disease Control and Prevention’s (CDC) Division of Cancer Prevention and Control (DCPC).
New Restrictions on Medicaid Eligibility Are Unreasonably Harsh and Will Be Life-Threatening for Cancer Patients
The U.S. Centers for Medicare & Medicaid Services (CMS) released today an interim final rule on work requirement implementation in Medicaid.
60 Cancer Patient and Provider Groups Urge Secretary Kennedy to Protect the Integrity of the US Preventive Services Task Force
Today, 60 organizations representing millions of cancer patients and survivors as well as the providers who care for them sent a letter to Health and Human Services (HHS) Secretary Kennedy conveying the importance of the US Preventive Services Task Force (USPSTF) in the fight against cancer and urging protection for the integrity of its work.
FDA’s Authorization of New Flavored E-Cigarette Products Threatens Progress in the Fight Against Cancer
Late Tuesday, May 5th, the Food and Drug Administration (FDA) announced the authorization of four new flavored e-cigarette products, including two non-tobacco, non-menthol flavors.
Bipartisan Legislation Aimed at Improving Access to Clinical Trials for Patients Introduced in the Senate
A new bill that would improve access to clinical trials was recently introduced in the U.S. Senate. Sponsored by Senators Tim Scott (R-S.C.) and Mark Warner (D-Va.), the Clinical Trial Modernization Act (S. 4440) would help reduce cost and geographic barriers, making it easier for patients to take part in clinical trials. U.S. Representatives Raul Ruiz (D-Calif.) and August Pfluger (R-Texas) introduced the House version (H.R. 3521) of this legislation in May 2025.
New Report Examines Gaps in Cancer Prevention, Treatment and Survivorship
WASHINGTON, DC – APRIL 16, 2026 – The American Cancer Society Cancer Action Network (ACS CAN) released a new report today showing the scope of cancer disparities in the United States and recommended local, state and federal policies that can help reduce them. Cancer Disparities: An American Cancer Society Cancer Action Network Chartbook examines disparities in cancer screening, prevention and early detection, disparities in cancer incidence, mortality and survival, as well as disparities in access to health coverage.
Congress Must Continue Bipartisan Commitment to Cancer Research and Prevention Funding Amid Insufficient Investment in President’s Budget
As the administration releases its proposed budget for Fiscal Year 2027, the American Cancer Society Cancer Action Network (ACS CAN) is calling on Congress to maintain its longstanding bipartisan commitment to robust, increased investments in cancer research and prevention.